87 related articles for article (PubMed ID: 8016606)
1. [Gastrointestinal hormone profile in medullary thyroid carcinoma].
Wirth HP; Eberle C; Meyenberger C; Bertschinger P; Häcki WH; Ammann R; Heitz PU
Schweiz Med Wochenschr; 1994 May; 124(21):906-11. PubMed ID: 8016606
[TBL] [Abstract][Full Text] [Related]
2. Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
Ide A; Ashizawa K; Ishikawa N; Ishii R; Ando T; Abe Y; Sera N; Usa T; Tominaga T; Ejima E; Nakashima M; Ito K; Ito K; Eguchi K
Thyroid; 2001 Nov; 11(11):1055-61. PubMed ID: 11762716
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma.
Modigliani E; Casanova S; Chayvialle JA; Bernard C; Franc B; Cohen R; Calmettes C
J Clin Endocrinol Metab; 1990 Oct; 71(4):831-5. PubMed ID: 1976126
[TBL] [Abstract][Full Text] [Related]
5. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
[TBL] [Abstract][Full Text] [Related]
6. Gastro-intestinal polypeptides in patients treated for medullary carcinoma of the thyroid.
Rasmusson B
Acta Endocrinol (Copenh); 1984 May; 106(1):112-5. PubMed ID: 6375228
[TBL] [Abstract][Full Text] [Related]
7. [Detection of remnants after removal of medullary thyroid carcinoma].
Zhang J; Dai W; Lian X; Meng X; Hu Y; Bai Y; Li F; Zhang B
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):19-21. PubMed ID: 11831978
[TBL] [Abstract][Full Text] [Related]
8. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.
Hanna FW; Ardill JE; Johnston CF; Cunningham RT; Curry WJ; Russell CF; Buchanan KD
J Endocrinol; 1997 Feb; 152(2):275-81. PubMed ID: 9071985
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-releasing peptide: pharmacokinetics and effects on gastro-entero-pancreatic hormones and gastric secretion in normal men.
Knigge U; Holst JJ; Knuhtsen S; Petersen B; Krarup T; Holst-Pedersen J; Christiansen PM
J Clin Endocrinol Metab; 1984 Aug; 59(2):310-5. PubMed ID: 6736205
[TBL] [Abstract][Full Text] [Related]
10. Serum calcitonin may falsely estimate tumor burden in chronic hypercalcemia: a case of prostatic and multiple bone metastases from medullary thyroid cancer.
Kim HK; Bae WK; Choi YD; Shim HJ; Yoon JH; Kang HC
Thyroid; 2014 Mar; 24(3):599-603. PubMed ID: 23985043
[TBL] [Abstract][Full Text] [Related]
11. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-releasing peptide directly releases pepsinogen from guinea pig chief cells.
Fiorucci S; McArthur KE
Am J Physiol; 1990 Nov; 259(5 Pt 1):G760-6. PubMed ID: 1700625
[TBL] [Abstract][Full Text] [Related]
13. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
15. [Immuno-histochemical study of medullary thyroid carcinoma].
Bessho T
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):872-84. PubMed ID: 2890090
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
17. Increase in cytoplasmic Ca2+ and stimulation of calcitonin secretion from human medullary thyroid carcinoma cells by the gastrin-releasing peptide.
Abe Y; Kanamori A; Yajima Y; Kameya T
Biochem Biophys Res Commun; 1992 Jun; 185(3):833-8. PubMed ID: 1627139
[TBL] [Abstract][Full Text] [Related]
18. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]